Initial clinical experience with durvalumab plus tremelimumab in patients with unresectable hepatocellular carcinoma in real‑world practice-Reference-Cited by-同舟云学术

Initial clinical experience with durvalumab plus tremelimumab in patients with unresectable hepatocellular carcinoma in real‑world practice

Published:2024-06-25 Issue:2 Volume:28 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Shimose Shigeo¹,Saeki Issei²,Tomonari Tetsu³,Ito Takanori⁴,Tani Joji⁵,Takeuchi Yasuto⁶,Yoshioka Naoki⁷,Naito Takehito⁸,Takeuchi Mamiko⁹,Kakizaki Satoru¹⁰,Hatanaka Takeshi¹¹,Sasaki Kyo¹²,Yasunaka Tetsuya¹³,Sakata Masahiro¹⁴,Iwamoto Hideki¹,Itano Satoshi¹⁵,Shirono Tomotake¹,Tanabe Norikazu¹⁶,Yamamoto Takafumi⁴,Naganuma Atsushi¹⁷,Nishina Soji¹²,Otsuka Motoyuki¹⁸,Kawashima Hiroki⁴,Takayama Tetsuji³,Takami Taro²,Kawaguchi Takumi¹

Affiliation:

1. Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka 830‑0011, Japan

2. Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi 755‑8505, Japan

3. Department of Gastroenterology and Oncology, Institute of Biomedical Sciences, Tokushima University Graduate School of Medicine, Tokushima 770‑8504, Japan

4. Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466‑8560, Japan

5. Department of Gastroenterology and Neurology, Kagawa University, Faculty of Medicine, Takamatsu, Kagawa 761‑0793, Japan

6. Department of Regenerative Medicine, Center for Innovative Clinical Medicine, Okayama University Hospital, Okayama 700‑8558, Japan

7. Department of Gastroenterology and Hepatology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Aichi 453‑8511, Japan

8. Department of Gastroenterology, Toyohashi Municipal Hospital, Toyohashi, Aichi 441‑8570, Japan

9. Department of Gastroenterology, Anjo Kosei Hospital, Anjo, Aichi 446‑8602, Japan

10. Department of Clinical Research, National Hospital Organization Takasaki General Medical Center, Takasaki, Gunma 370‑0829, Japan

11. Department of Gastroenterology, Gunma Saiseikai Maebashi Hospital, Maebashi, Gunma 371‑0821, Japan

12. Department of Gastroenterology, Kawasaki Medical School, Kurashiki, Okayama 701‑0192, Japan

13. Department of Gastroenterology, Fukuyama City Hospital, Fukuyama, Okayama 721‑8511, Japan

14. Department of Gastroenterology, Fukuyama Medical Center, Fukuyama, Okayama 720‑8520, Japan

15. Department of Gastroenterology and Hepatology, Kurume Central Hospital, Kurume, Fukuoka 830‑0001, Japan

16. Division of Laboratory, Yamaguchi University Hospital, Ube, Yamaguchi 755‑8505, Japan

17. Department of Gastroenterology, National Hospital Organization Takasaki General Medical Center, Takasaki, Gunma 370‑0829, Japan

18. Department of Gastroenterology and Hepatology, Okayama University Hospital, Okayama 700‑8558, Japan

Publisher

Spandidos Publications

Reference37 articles.

1. Global burden of primary liver cancer in 2020 and predictions to 2040;Rumgay;J Hepatol,2022

2. Hepatocellular carcinoma;Vogel;Lancet,2022

3. Hepatocellular carcinoma;Villanueva;N Engl J Med,2019

4. Recent advances in systemic therapy for hepatocellular carcinoma in an aging society: 2020 update;Kudo;Liver Cancer,2020

5. Combination immunotherapy for hepatocellular carcinoma;Rimassa;J Hepatol,2023

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Opportunities and challenges of multidisciplinary conversion therapy in advanced hepatocellular carcinoma;Current Cancer Reports;2024-09-11